Application no. and date | 19745925.8 (espacenet) (Federated) (European Patent Register), 20190711 | Patent/reg. no. and date | DK/EP 3820873, 20221123 | Publication date | 20210519 | Priority no. and date | US 201862697100 P, 20180712 | EP pub. no. and date |
EP 3820873 20210519 | Effective date | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | V450687DK00 | Inventor | MCMAHON, Jennifer Anne, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, RUBIO, Almudena, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, BASTIAN, Jolie Anne, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, SALL, Daniel Jon, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US, COHEN, Jeffrey Daniel, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/436 (2006.01) , A61P 35/00 (2006.01) , C07D 491/052 (2006.01) | Title | Selektive østrogenreceptornedbrydere | Int. application no. | US2019041334 | Int. publication no. | WO2020014435 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|